Toolkit/Mutational analysis of IgE-binding sites

Mutational analysis of IgE-binding sites

Assay Method·Research·Since 2000

Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

Specific linear IgE-binding epitopes have recently been identified, and mutational analysis is underway.

Usefulness & Problems

Why this is useful

This method tests how sequence changes affect IgE recognition of allergen epitopes. The review presents it as a route toward therapeutically useful reduced-binding variants.; testing how amino-acid substitutions alter IgE binding; supporting therapeutic redesign of allergen proteins

Source:

This method tests how sequence changes affect IgE recognition of allergen epitopes. The review presents it as a route toward therapeutically useful reduced-binding variants.

Source:

testing how amino-acid substitutions alter IgE binding

Source:

supporting therapeutic redesign of allergen proteins

Problem solved

It helps determine whether specific residues are critical for IgE binding.; identifies substitutions that may reduce allergen-antibody recognition

Source:

It helps determine whether specific residues are critical for IgE binding.

Source:

identifies substitutions that may reduce allergen-antibody recognition

Problem links

identifies substitutions that may reduce allergen-antibody recognition

Literature

It helps determine whether specific residues are critical for IgE binding.

Source:

It helps determine whether specific residues are critical for IgE binding.

Taxonomy & Function

Primary hierarchy

Technique Branch

Method: A concrete measurement method used to characterize an engineered system.

Target processes

No target processes tagged yet.

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor

It requires prior epitope identification and the ability to generate altered allergen sequences or proteins.; requires mapped epitopes and engineered protein variants

The review does not show that reduced binding automatically translates into safe or effective therapy.; described as underway for soy and not fully resolved in the review

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1review summarysupports2000Source 1needs review

Elimination of all legumes in individuals with clinical reactions to one legume is generally unwarranted despite frequent multiple positive legume tests.

Claim 2review summarysupports2000Source 1needs review

Epitope analysis suggests that linear IgE-binding epitopes are prominent in major peanut allergens and that some single amino-acid substitutions can reduce IgE binding, implying therapeutic potential.

Claim 3review summarysupports2000Source 1needs review

Molecular studies indicate that peanut and soy contain both homologous and unique allergenic proteins, helping explain why serologic cross-reactivity does not always produce clinical coallergy.

Claim 4review summarysupports2000Source 1needs review

Serologic or skin-test cross-reactivity between peanut and soy is common, but clinically important peanut-soy coallergy is uncommon.

clinical soy reactivity in peanut allergic children 3%coallergy rate atopic dermatitis cohort 1 0.8%coallergy rate atopic dermatitis cohort 2 1.8%soy reactivity among severe peanut allergy cases 6.5%

Approval Evidence

1 source2 linked approval claimsfirst-pass slug mutational-analysis-of-ige-binding-sites
Specific linear IgE-binding epitopes have recently been identified, and mutational analysis is underway.

Source:

review summarysupports

Epitope analysis suggests that linear IgE-binding epitopes are prominent in major peanut allergens and that some single amino-acid substitutions can reduce IgE binding, implying therapeutic potential.

Source:

review summarysupports

Molecular studies indicate that peanut and soy contain both homologous and unique allergenic proteins, helping explain why serologic cross-reactivity does not always produce clinical coallergy.

Source:

Comparisons

Source-stated alternatives

The review places mutational analysis alongside epitope mapping and broader molecular characterization.

Source:

The review places mutational analysis alongside epitope mapping and broader molecular characterization.

Source-backed strengths

the review states that single amino-acid substitutions often lead to loss of binding

Source:

the review states that single amino-acid substitutions often lead to loss of binding

Mutational analysis of IgE-binding sites and Langendorff perfused heart electrical recordings address a similar problem space.

Shared frame: same top-level item type

Strengths here: looks easier to implement in practice.

Mutational analysis of IgE-binding sites and native green gel system address a similar problem space.

Shared frame: same top-level item type

Strengths here: looks easier to implement in practice.

Mutational analysis of IgE-binding sites and sub-picosecond pump-probe analysis of bacteriorhodopsin pigments address a similar problem space.

Shared frame: same top-level item type

Strengths here: looks easier to implement in practice.

Ranked Citations

  1. 1.
    StructuralSource 1Allergy2000Claim 1Claim 2Claim 3

    Seeded from load plan for claim cl6. Extracted from this source document.